Evaluation of BIS for Quantification of Lymphedema

CompletedOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Breast Cancer
Interventions
OTHER

Bioimpedance Spectroscopy

BIS used to measure fluid in arm

Trial Locations (1)

02215

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01544335 - Evaluation of BIS for Quantification of Lymphedema | Biotech Hunter | Biotech Hunter